Tural, D. Et Al. 2021. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.8 , 1506-1513.

Tural, D., Olmez, O. F., Sumbul, A. T., Ozhan, N., ÇAKAR, B., Kostek, O., ... Ekenel, M.(2021). Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.8, 1506-1513.

Tural, Deniz Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.8, 1506-1513, 2021

Tural, Deniz Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.8, pp.1506-1513, 2021

Tural, D. Et Al. (2021) . "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.8, pp.1506-1513.

@article{article, author={Deniz Tural Et Al. }, title={Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2021, pages={1506-1513} }